Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 12Neuroendocrine Tumors 5Neoplasm Metastasis 5Carcinoma, Renal Cell 4Triple Negative Breast Neoplasms 3Adenoma, Islet Cell 3Recurrence 2Meningioma 2Glioblastoma 2Diffuse Intrinsic Pontine Glioma 2Carcinoma, Hepatocellular 2Carcinoid Tumor 2von Hippel-Lindau Disease 1Unilateral Breast Neoplasms 1Tuberous Sclerosis 1Thymus Neoplasms 1Sarcoma 1Neoplasms 1Metastatic Digestive System Neuroendocrine Tumor G1 1Lymphangioleiomyomatosis 1Locally Advanced Thyroid Gland Carcinoma 1Kidney Neoplasms 1Hormone Receptor Positive Breast Cancer 1HR+/HER2- Advanced Breast Cancer 1Glioma 1Gastroenteropancreatic Neuroendocrine Tumors 1Gastro-enteropancreatic neuroendocrine tumor 1Gallbladder Neoplasms 1Disease Progression 1Colorectal Neoplasms 1

Interventions

Tablets 1Genetic Testing 1Everolimus 1Blood Specimen Collection 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hormone Receptor Positive Breast Cancer × Everolimus × Clear all
NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Recruiting
19 enrolled
Breast

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡